Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 94 Records) |
| Query Trace: Neoplasms and ABCC2[original query] |
|---|
| Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenetics and genomics 2018 Aug . Zgheib Nathalie K, Ghanem Khaled M, Tamim Hani, Aridi Carole, Shahine Randa, Tarek Nidale, Saab Raya, Abboud Miguel R, El-Solh Hassan, Muwakkit Samar |
| Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients. Clinical breast cancer 2018 May . Jabir Rafid Salim, Ho Gwo Fuang, Annuar Muhammad Azrif Bin Ahmad, Stanslas Johns |
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
| Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2757-2764. Treenert Apatsara, Areepium Nutthada, Tanasanvimon Suebpo |
| Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial. Pharmacogenetics and genomics 2018 11 28 (11): 245-250. Ruiz-Pinto Sara, Martin Miguel, Pita Guillermo, Caronia Daniela, de la Torre-Montero Julio C, Moreno Leticia T, Moreno Fernando, García-Sáenz José Á, Benítez Javier, González-Neira An |
| Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients. Journal of oncology 2019 2019 6425708. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
| Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Scientific reports 2019 Aug 9 (1): 11527. Ruzzo Annamaria, Graziano Francesco, Galli Francesca, Galli Fabio, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Bagaloni Irene, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? The pharmacogenomics journal 2019 Feb . Nichetti Federico, Falvella Felicia Stefania, Miceli Rosalba, Cheli Stefania, Gaetano Raffaella, Fucà Giovanni, Infante Gabriele, Martinetti Antonia, Antoniotti Carlotta, Falcone Alfredo, Di Bartolomeo Maria, Cremolini Chiara, de Braud Filippo, Pietrantonio Filip |
| ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study. Cancer chemotherapy and pharmacology 2019 Feb . De Troia Beatrice, Dalu Davide, Filipazzi Virginio, Isabella Luigi, Tosca Nicoletta, Ferrario Sabrina, Gambaro Anna Rita, Somma Luisa, Fasola Cinzia, Cheli Stefania, Clementi Emilio, De Francesco Davide, Falvella Felicia Stefania, Cattaneo Maria Tere |
| ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects. European journal of clinical pharmacology 2019 Nov . Cao Kangna, Ren Guanghui, Lu Chengcan, Wang Yao, Tan Yanan, Zhou Jing, Zhang Yongjie, Lu Yang, Li Ning, Chen Xijing, Zhao |
| Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients. Carcinogenesis 2019 Jan . Gentiluomo Manuel, Puchalt García Paula, Galeotti Alice Alessandra, Talar-Wojnarowska Renata, Tjaden Christine, Tavano Francesca, Strobel Oliver, Kupcinskas Juozas, Neoptolemos John, Hegyi Péter, Costello Eithne, Pezzilli Raffaele, Sperti Cosimo, Lawlor Rita T, Capurso Gabriele, Szentesi Andrea, Soucek Pavel, Vodicka Pavel, Lovecek Martin, Hackert Thilo, Cavestro Giulia Martina, Milanetto Anna Caterina, Canzian Federico, Campa Danie |
| ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. Cancer chemotherapy and pharmacology 2020 Aug . Nomura Hisanaga, Tsuji Daiki, Demachi Ken, Mochizuki Nobuo, Matsuzawa Haruki, Yano Tomonori, Daiko Hiroyuki, Fujii Satoshi, Kojima Takashi, Itoh Kunihiko, Kawasaki Toshikat |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster. BMC medical genetics 2020 11 21 (1): 225. Brandi Giovanni, Rizzo Alessandro, Deserti Marzia, Relli Valeria, Indio Valentina, Bin Sofia, Pariali Milena, Palloni Andrea, De Lorenzo Stefania, Tovoli Francesco, Tavolari Simo |
| A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. BMC cancer 2021 Sep 21 (1): 1030. Cordova-Delgado Miguel, Bravo María Loreto, Cumsille Elisa, Hill Charlotte N, Muñoz-Medel Matías, Pinto Mauricio P, Retamal Ignacio N, Lavanderos María A, Miquel Juan Francisco, Rodriguez-Fernandez Maria, Liao Yuwei, Li Zhiguang, Corvalán Alejandro H, Armisén Ricardo, Garrido Marcelo, Quiñones Luis A, Owen Gareth |
| Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. Esophagus : official journal of the Japan Esophageal Society 2021 Aug . Fujita Kazuma, Motoyama Satoru, Sato Yusuke, Wakita Akiyuki, Nagaki Yushi, Minamiya Yoshihiro, Miura Masato |
| Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy. Cancer chemotherapy and pharmacology 2021 Jul . Duran Goretti, Cruz Raquel, Aguín Santiago, Barros Francisco, Giráldez José María, Bernárdez Beatriz, Zarra Irene, López-López Rafael, Carracedo Ángel, Lamas María Jes |
| Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Frontiers in cardiovascular medicine 2021 8 651269. Yang Xinyu, Li Guoping, Guan Manke, Bapat Aneesh, Dai Qianqian, Zhong Changming, Yang Tao, Luo Changyong, An Na, Liu Wenjing, Yang Fan, Pan Haie, Wang Pengqian, Gao Yonghong, Gong Ye, Das Saumya, Shang Hongcai, Xing Yanw |
| Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
| Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
| Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. Journal of inflammation research 2021 11 14 5403-5417. Zhang Yu, Zhang Xin, Jin Zhuoyi, Chen Huiyan, Zhang Chenjing, Wang Wangyue, Jing Jiyong, Pan Wenshe |
| Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer. Investigational new drugs 2022 9 40 (6): 1254-1262. Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Fukuda Natsuki, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
| Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane. The journal of gene medicine 2022 Jun e3434. Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi |
| Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis. Clinical and translational science 2022 May . Atasilp Chalirmporn, Biswas Mohitosh, Jinda Pimonpan, Nuntharadthanaphong Nutthan, Rachanakul Jiratha, Hongkaew Yaowaluck, Vanwong Natchaya, Saokaew Surasak, Sukasem Chonlaph |
| Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022 Feb 14 (2): . Sendra Luis, Olivera Gladys G, López-Andújar Rafael, Serrano Cristina, Rojas Luis E, Montalvá Eva María, Herrero María José, Aliño Salvador |
| Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 2022 12 e23269. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
| Predictive Value of ABCC2 and UGT1A1 Polymorphisms on Irinotecan-Related Toxicities in Patients with Cancer. Genetic testing and molecular biomarkers 2023 5 27 (5): 133-141. Zineb Aoullay, Andrew Smith, Meriem Slaoui, Ihssane El Bouchikhi, Hassan Ghazal, Najib Al Idrissi, Bouchra Meddah, Kara L Lynch, Yahia Cherrah, Alan H B |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: